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SUMMARY. Cyclosporine A (CsA) is a cyclic peptide widely used as an immunosuppressant. Therapeutic
drug monitoring (TDM) of CsA is becoming mandatory for transplant patients who received CsA therapy
in the routine clinical practice because of large individual variability, dose-related toxicity and the risk of
acute rejection. In this study, a rapid, sensitive, and selective LC-MS/MS method was developed and vali-
dated for the quantitative analysis of free CsA (fCsA), a better indicator for the prediction of efficacy and
safety of CsA-based therapy. Following ultrafiltration for fCsA, chromatographic separation was per-
formed on an Agilent Zorbax SB-C18 column (100 mm x 2.1 mm, 3.5 μm ) with acetonitrile and 0.1 % am-
monium hydroxide in water (85:15, v/v) as the mobile phases. The compounds were quantified by positive
electrospray ionization tandem mass spectrometry. Selectivity, linearity, accuracy, precision, recovery,
and stability were evaluated during method validation. The validated method was applied to a single blood
concentration measurement 2 h after CsA administration (C2) measurement study of fCsA after an oral
administration of a single 15 mg/kg intravenous dose of CsA to six rabbits.
